Showing 1181-1190 of 1717 results for "".
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0805DementiaInsights-pdf/31414/Statins and Alzheimer's Disease: Evaluating the Potential for PreventionRecent discussions in clinical neurology have revisited the intriguing possibility that statin-type HMG-CoA reductase inhibitors, widely prescribed for hyperlipidemia, may play a role in preventing or treating Alzheimer’s Diseas
- Expert Opinionhttps://practicalneurology.com/diseases-diagnoses/imaging-testing/PN0605ExpertOpinion-pdf/31440/Unilateral Paresthesias Due to Hyperventilation Syndrome: A Clinical InsightIn the article "Unilateral Paresthesias Due to Hyperventilation Syndrome," Dr. Randolph W. Evans presents a comprehensive analysis of a 53-year-old male patient exhibiting dizziness and tingling in the left ankle, initially
- Will the Medical Liability Crisis Hammer Your Practice?https://practicalneurology.com/archives/2005-june/PN0605malpractice-pdf/31441/Medical Malpractice Reform: Navigating the Ongoing Liability CrisisMedical malpractice reform remains a critical yet contentious issue within the healthcare sector, as highlighted in the June 2005 issue of *Practical Neurology*. Despite sustained advocacy by physicians, national progress on liabilit
- Vascular Clinichttps://practicalneurology.com/diseases-diagnoses/stroke/PN0505Vascular-pdf/31460/Intracranial stenosis, responsible for 10-15% of all strokes and more prevalent among non-Caucasian populations such as Asians and African Americans, remains a critical yet under-researched area in vascular neurology. Historically, the medical management of intracranial stenosis lacked robust prospe
- Vascular Clinichttps://practicalneurology.com/diseases-diagnoses/stroke/0305VasClinicforWeb-pdf/31476/Recent developments in antiplatelet therapy for ischemic stroke patients have prompted a reevaluation of clopidogrel (Plavix) usage, particularly in those with aspirin intolerance. The Management of Atherothrombosis with Clopidogrel in High-risk Patients (MATCH) trial previously indicated that combi
- MS Diagnosis: Sizing Up the Suspectshttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pn0205pg52-56-pdf/31493/Diagnosing multiple sclerosis (MS) remains one of the most challenging tasks in neurology due to its diverse clinical presentations and numerous mimicking conditions. In Jeffrey I. Greenstein’s February 2005 article in *Practical Neurology*, the complexities of differentiating MS from other neurolog
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0205pg59-60-pdf/31494/Optimizing Antiseizure Medication Selection in Epilepsy ManagementThe terminology surrounding epilepsy treatment is evolving, with increasing advocacy for the term “anti-seizure drugs” (ASDs) over the traditional “antiepileptic drugs” (AEDs). This shift emphasizes the role of these medications in su
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31498/Implementing Strategic Plans in Neurology Practices: Essential Financial Tools for SuccessDeveloping a strategic plan is a critical step for neurology practices aiming to achieve long-term success. However, the true challenge lies not just in creating the plan but in effectively implementing it. A c
- Which Candidate Has the Best Healthcare Plan for America?https://practicalneurology.com/columns/practice-management/which-candidate-has-the-best-healthcare-plan-for-america/30977/In the 2008 presidential campaign, healthcare emerged as a pivotal issue, intertwining with economic concerns such as Wall Street bailouts and regulatory challenges. Healthcare experts highlight the critical link between the nation’s economic strength and the inefficiencies and rising costs of the A
- Managing Sleep and Sleepiness in Parkinson's Diseasehttps://practicalneurology.com/diseases-diagnoses/sleep/pn0908-sleep-and-pd-pdf/30998/Sleep disturbances are highly prevalent in patients with Parkinson’s Disease (PD), affecting between 60% and 98% of individuals. These disturbances encompass a range of issues, including nocturnal sleep fragmentation, reduced slow-wave and REM sleep, decreased total sleep time, and impaired sleep ef